12 October 2023
12 October 2023
The Chinese company obtained an EU class D in vitro diagnostic regulation certification for rapid tests.
Brainomix and Nanoflex Robotics will join forces to deliver an AI-assisted magnetic navigation system for robotic surgical tools with funding from Switzerland and the UK.
The US based supplier of blood and plasma devices has acquired Opensens in a bid to expand its offerings out into the interventional cardiology market.
Daye, known for its unique tampons, has partnered with CRO Lindus Health to conduct the trial.
It is claimed to be the first digital PCR based kit for detecting POLE mutations.
GE Healthcare will own the global rights to [68Ga]FAPI-46 and the rights outside the US for [18F]FAPI-74.
The test will help physicians evaluate pathologies associated with Alzheimer's disease and other neurodegenerative conditions.
The tiny injectable is placed near the nerve through a 17-gauge needle under the guidance of ultrasound.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Give your business an edge with our leading industry insights.
